|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 501.00 GBX | +0.70% |
|
+0.80% | -7.05% |
| 05-08 | HgCapital Trust net asset value falls despite "strong" first quarter | AN |
| 05-08 | UK court upholds watchdog's finding on excessive NHS thyroid drug prices | RE |
| Capitalization | 2.29B 3.12B 2.69B 2.53B 4.23B 268B 4.77B 29.49B 11.49B 123B 11.7B 11.45B 449B | P/E ratio 2023 |
8.63x | P/E ratio 2024 | 10.4x |
|---|---|---|---|---|---|
| Enterprise value | 2.33B 3.17B 2.74B 2.57B 4.3B 272B 4.85B 29.99B 11.69B 125B 11.9B 11.65B 457B | EV / Sales 2023 |
6.69x | EV / Sales 2024 | 9.63x |
| Free-Float |
90.69% | Yield 2023 |
1.5% | Yield 2024 | 1.02% |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | +0.70% | ||
| 1 week | +0.80% | ||
| 1 month | +0.40% | ||
| 3 months | -1.38% | ||
| 6 months | -3.09% | ||
| Current year | -7.05% |
| 1 week | 492 |  | 509 |
| 1 month | 486.66 | | 515 |
| Current year | 420 | | 545 |
| 1 year | 420 | | 550 |
| 3 years | 310 | | 550 |
| 5 years | 231 | | 550 |
| 10 years | 98.1 | | 550 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 31/12/2009 | |
Matthew Barry
DFI | Director of Finance/CFO | - | 31/07/2012 |
David Toms
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Brooman
BRD | Director/Board Member | 70 | 10/10/2007 |
James Strang
CHM | Chairman | 53 | 11/05/2020 |
Pilar Junco
BRD | Director/Board Member | 49 | 19/07/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.70% | +0.80% | +5.92% | +34.50% | 3.1B | ||
| +1.26% | +0.25% | +11.36% | +36.43% | 15.77B | ||
| +0.28% | -0.18% | +8.57% | +35.40% | 7.12B | ||
| +1.01% | 0.00% | +1.52% | +30.16% | 6.42B | ||
| +1.33% | +0.44% | +4.75% | +81.53% | 5.33B | ||
| +0.94% | +0.37% | -5.80% | +30.41% | 4.2B | ||
| -0.17% | +1.20% | -12.27% | -21.85% | 3.57B | ||
| +0.53% | -1.87% | +6.78% | -18.18% | 3.57B | ||
| 0.00% | -2.39% | +7.76% | +21.35% | 3.54B | ||
| +0.41% | +0.93% | +18.62% | +19.63% | 3.27B | ||
| Average | +0.63% | -0.03% | +4.72% | +24.94% | 5.59B | |
| Weighted average by Cap. | +0.79% | -0.16% | +6.05% | +30.17% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 256M 348M 300M 282M 472M 29.9B 533M 3.29B 1.28B 13.7B 1.31B 1.28B 50.15B | 260M 354M 305M 287M 480M 30.4B 541M 3.35B 1.3B 13.93B 1.33B 1.3B 50.99B |
| Net income | 231M 313M 270M 254M 425M 26.93B 480M 2.96B 1.16B 12.34B 1.18B 1.15B 45.17B | 236M 321M 277M 260M 435M 27.58B 491M 3.04B 1.18B 12.64B 1.2B 1.18B 46.26B |
| Net Debt | -275M -375M -323M -304M -508M -32.18B -573M -3.54B -1.38B -14.74B -1.41B -1.38B -53.97B | 39.1M 53.16M 45.87M 43.12M 72.09M 4.57B 81.35M 503M 196M 2.09B 199M 195M 7.66B |
More financial data
* Estimated data
Employees
-
Sector
Investment Trusts
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/25 | 501.00 p | +0.70% | 575,039 |
| 13/06/25 | 497.50 p | -1.68% | 318,078 |
| 12/06/25 | 506.00 p | +0.20% | 283,837 |
| 11/06/25 | 505.00 p | +0.40% | 480,842 |
| 10/06/25 | 503.00 p | +1.72% | 569,222 |
Delayed Quote London S.E., June 16, 2025 at 04:35 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.010GBP
Average target price
5.450GBP
Spread / Average Target
+8.78%
Annual profits - Rate of surprise
- Stock Market
- Equities
- HGT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition